[HTML][HTML] Abortion safety and use with normally prescribed mifepristone in Canada

L Schummers, EK Darling, S Dunn… - … England Journal of …, 2022 - Mass Medical Soc
Abstract Background In the United States, mifepristone is available for medical abortion (for
use with misoprostol) only with Risk Evaluation and Mitigation Strategy (REMS) restrictions …

[PDF][PDF] Departament de salut

G de Catalunya - Manual de vacunacions. Col· leció: Quaderns …, 2008 - igualtat.gencat.cat
La incorporació de la interrupció voluntària de l'embaràs (IVE) a la cartera de serveis
públics del Servei Català de la Salut a l'any 2010 va implicar una ordenació dels serveis per …

Combination of Mifepristone and Misoprostol for First-Trimester Medical Abortion: A Comprehensive Review of the Literature

V Kelesidou, I Tsakiridis, A Virgiliou… - Obstetrical & …, 2024 - journals.lww.com
Combination of Mifepristone and Misoprostol for First-Trimes... : Obstetrical & Gynecological Survey
Combination of Mifepristone and Misoprostol for First-Trimester Medical Abortion: A …

Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling

DJ Costescu - International journal of women's health, 2016 - Taylor & Francis
Unintended pregnancy is a significant global problem. In 2008, there were over 100 million
unplanned pregnancies worldwide, representing approximately 41% of global conceptions …

Perspectives among Canadian physicians on factors influencing implementation of mifepristone medical abortion: a national qualitative study

S Munro, E Guilbert, MS Wagner… - The Annals of Family …, 2020 - Annals Family Med
PURPOSE Access to family planning health services in Canada has been historically
inadequate and inequitable. A potential solution appeared when Health Canada approved …

Medication abortion with misoprostol-only: a sample protocol

EG Raymond, A Mark, D Grossman, A Beasley… - Contraception, 2023 - Elsevier
Mifepristone approval by the United States (US) Food and Drug Administration in 2000
revolutionized abortion care in this country. In 2020, 53% of people having facility-based …

Abortion services and providers in Canada in 2019: results of a national survey

RM Renner, M Ennis, D Contandriopoulos… - … Open Access Journal, 2022 - cmajopen.ca
Background: Since 2016, abortion care has undergone several important changes,
particularly related to the provision of medical abortion using mifepristone. We aimed to …

No. 360-induced abortion: surgical abortion and second trimester medical methods

D Costescu, É Guilbert - Journal of Obstetrics and Gynaecology Canada, 2018 - Elsevier
Objective This guideline reviews evidence relating to the provision of surgical induced
abortion (IA) and second trimester medical abortion, including pre-and post-procedural care …

Barriers and enablers to nurse practitioner implementation of medication abortion in Canada: a qualitative study

A Carson, E Stirling-Cameron, M Paynter, S Munro… - Plos one, 2023 - journals.plos.org
In this study we explored nurse practitioner-provided medication abortion in Canada and
identified barriers and enablers to uptake and implementation. Between 2020–2021, we …

Pharmacist checklist and resource guide for mifepristone medical abortion: user-centred development and testing

N Rebic, S Munro, WV Norman… - … Journal/Revue des …, 2021 - journals.sagepub.com
Methods Our study is embedded in an observational mixed-methods research program, the
Contraception and Abortion Research Team (CART)–Mifepristone Implementation Study. 3 …